PepGen Inc. Common Stock

Go to PepGen Inc. Common Stock Website

$1.35

0.03 (2.27%)
Live
Previous Close

$1.37

Day Range

$1.25 - $1.43

Previous Day Range

$1.3 - $1.39

Market Cap

$43.2 million USD

Day Vol.

135871

Previous Day Vol.

107234

Currency

USD

Primary Exchange

Nasdaq

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleo...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

A class action lawsuit has been filed against PepGen alleging false and misleading statements about their drug PGN-EDO51's effectiveness and safety during the period of March 7, 2024 to March 3, 2025.

Related tickers: PEPG.

Read Full Article

Pomerantz LLP filed a class action lawsuit against PepGen Inc. for allegedly making false and misleading statements about its Duchenne muscular dystrophy drug PGN-EDO51, which failed to meet clinical trial expectations and was ultimately discontinued.

Related tickers: PEPG.

Read Full Article
Trending Tickers

Please sign in to view